Related Experiment Video
Updated: May 19, 2026

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model
Published on: February 7, 2022
Has late rejection decreased in pediatric heart transplantation in the current era? A multi-institutional study
Rebecca K Ameduri1, Jie Zheng, Kenneth B Schechtman
1Division of Pediatric Cardiology, University of Minnesota Amplatz Children's Hospital, Minneapolis, MN 55454, USA. amedu001@umn.edu
Insights
Late rejection after pediatric heart transplantation has decreased but still significantly increases mortality and coronary vasculopathy risk. Improved prevention strategies are crucial for long-term outcomes in these young patients.
Area of Science:
- Pediatric Cardiology
- Transplantation Immunology
- Cardiovascular Research
Background:
- Late rejection (LR), occurring over a year post-transplant, is a significant risk factor for mortality and morbidity in pediatric heart transplant recipients.
- While early rejection rates have declined in recent years, the impact of LR remains a concern.
- This study investigates whether the incidence of LR has also decreased in the current era.
Purpose of the Study:
- To analyze trends in the prevalence of late rejection (LR) after pediatric heart transplantation (HTx) between different eras.
- To examine the relationship between LR and key adverse outcomes, including mortality, coronary artery vasculopathy (CAV), and retransplantation.
- To identify independent risk factors associated with LR in pediatric HTx recipients.
Main Methods:
- Utilized the Pediatric Heart Transplant Study database for comprehensive analysis.
- Compared data from two distinct eras: 1993-1998 (earlier) and 1999-2007 (current).
- Assessed the effects of era and other factors on LR prevalence and its association with mortality, CAV, and retransplantation.
Main Results:
- Freedom from first and recurrent LR was significantly lower in the current era compared to the earlier era (5-year post-HTx: 69% vs 59%).
- LR was strongly associated with early rejection (ER) in both eras.
- Independent risk factors for LR included: earlier era, non-white race, older recipient age, recipient Status 2, and male donor.
Conclusions:
- Late rejection has decreased in pediatric heart transplant recipients in the recent era.
- The detrimental effects of LR on mortality and the development of moderate-severe CAV or retransplantation have remained consistent over time.
- Enhanced primary prevention strategies are essential to mitigate the ongoing risks associated with LR.
Background:
Late (occurring >1 year) rejection (LR) has been shown to increase mortality and morbidity after pediatric heart transplantation (HTx). The incidence of rejection has decreased in the first year after pediatric HTx in the current era. We hypothesized a similar phenomenon has occurred with LR.
Methods:
The Pediatric Heart Transplant Study database was used to analyze the effects of era (1993 to 1998 vs 1999 to 2007) and other factors on the prevalence of LR and its relationship to mortality, moderate-severe coronary vasculopathy (CAV) and retransplantation.
Results:
Freedom from first LR (59% vs 69% 5-year post-HTx, p < 0.001) and recurrent LR (p < 0.001) was significantly lower in the current vs earlier era. LR was significantly (p < 0.001) associated with early rejection (ER; rejection <1 year post-HTx) in both eras. Independent risk factors for LR were: earlier era (hazard ratio [HR] 1.47, 95% confidence interval [CI] 1.25 to 1.73, p < 0.001); non-white race (HR 1.41; 95% CI 1.19 to 1.67, p < 0.001); older recipient age (HR 1.05, 95% CI 1.03 to 1.06, p < 0.001); recipient Status 2 at transplant (HR 1.21, 95% CI 1.01 to 1.45, p = 0.037); and male donor (HR 1.17; 95% CI 1.0 to 1.37, p = 0.055). Late rejectors had a similar higher risk of mortality (odds ratio [OR] 4.20, 95% CI 3.04 to 5.81, p < 0.001) and incidence of moderate-severe CAV or retransplantation (OR 2.63, 95% CI 1.78 to 3.90, p < 0.001) in both eras.
Conclusions:
LR has decreased in the recent era in pediatric HTx recipients. Its effect on mortality and the development of CAV has not changed over time, suggesting an ongoing need for improved primary prevention strategies.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
